Bruker Co. (NASDAQ:BRKR – Get Rating)’s stock price gapped down prior to trading on Thursday . The stock had previously closed at $68.32, but opened at $65.08. Bruker shares last traded at $64.88, with a volume of 4,480 shares trading hands.
Wall Street Analyst Weigh In
Several analysts have issued reports on BRKR shares. The Goldman Sachs Group dropped their price objective on Bruker from $73.00 to $60.00 and set a “sell” rating on the stock in a research note on Wednesday, April 13th. StockNews.com downgraded Bruker from a “strong-buy” rating to a “buy” rating in a research report on Saturday, July 16th.
Bruker Stock Down 1.5 %
The firm has a 50-day moving average price of $63.54 and a 200 day moving average price of $64.09. The company has a debt-to-equity ratio of 1.19, a current ratio of 2.55 and a quick ratio of 1.72. The company has a market cap of $9.33 billion, a price-to-earnings ratio of 34.52, a P/E/G ratio of 1.69 and a beta of 1.17.
Bruker Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, June 17th. Investors of record on Wednesday, June 1st were given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend was Tuesday, May 31st. Bruker’s dividend payout ratio is currently 11.05%.
Institutional Investors Weigh In On Bruker
A number of large investors have recently added to or reduced their stakes in BRKR. National Bank of Canada FI acquired a new stake in Bruker during the fourth quarter worth approximately $27,000. Allspring Global Investments Holdings LLC acquired a new stake in Bruker during the fourth quarter worth approximately $10,516,000. CWM LLC acquired a new stake in Bruker during the fourth quarter worth approximately $292,000. Robeco Institutional Asset Management B.V. grew its position in Bruker by 92.8% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 5,589 shares of the medical research company’s stock worth $469,000 after buying an additional 2,690 shares in the last quarter. Finally, Xponance Inc. grew its position in Bruker by 90.2% during the fourth quarter. Xponance Inc. now owns 22,034 shares of the medical research company’s stock worth $1,849,000 after buying an additional 10,452 shares in the last quarter. Institutional investors and hedge funds own 76.09% of the company’s stock.
Bruker Company Profile
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies.
- Get a free copy of the StockNews.com research report on Bruker (BRKR)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc’s Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It’s Cheap
Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.